Zobrazeno 1 - 10
of 11
pro vyhledávání: '"Ho Shun Cheng"'
Autor:
Hui-Ling Hsieh, Shih-Chang Hsu, Ho-Shun Cheng, Chun-You Chen, Wen-Cheng Huang, Yuh-Mou Sue, Feng-Yen Lin, Chun-Ming Shih, Jaw-Wen Chen, Shing-Jong Lin, Po-Hsun Huang, Chung-Te Liu
Publikováno v:
PLoS ONE, Vol 15, Iss 1, p e0228405 (2020)
BACKGROUND:Atrial fibrillation (AF) is highly prevalent, occurring in 1%-2% of the adult population, increasing the risk of stroke, and resulting in considerable healthcare costs. While stroke is a major complication of AF, end-stage renal disease (E
Externí odkaz:
https://doaj.org/article/8132cf1e8b9c4e95bdf5fd2c0ef83d9c
Autor:
Chi-Heng, Kuo, Te-I, Chang, Cheng-Hsien, Chen, Chun-You, Chen, Hui-Ling, Hsieh, Shih-Chang, Hsu, Ho-Shun, Cheng, Yuh-Mou, Sue, Tso-Hsiao, Chen, Yung-Ho, Hsu, Feng-Yen, Lin, Chun-Ming, Shih, Po-Hsun, Huang, Chung-Te, Liu
Publikováno v:
Medicine. 101:e30835
While arteriovenous fistula (AVF) nonmaturation is a major issue of hemodialysis care, an effective treatment to improve AVF maturation remains lacking. AVF introduces pulsatile arterial blood flow into its venous limb and produces high luminal press
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::47384480ad5d3a34ef2071b06081d6fe
https://doi.org/10.1097/md.0000000000030835
https://doi.org/10.1097/md.0000000000030835
Autor:
Chung Te Liu, Yuh Mou Sue, Shing Jong Lin, Ho Shun Cheng, Te I. Chang, Feng Yen Lin, Po Hsun Huang, Chun You Chen, Cheng Hsien Chen, Yung Ho Hsu, Hui Ling Hsieh, Chun Ming Shih, Shih Chang Hsu, Wen Cheng Huang
Publikováno v:
Scientific Reports, Vol 10, Iss 1, Pp 1-8 (2020)
Scientific Reports
Scientific Reports
While the patency of vascular access is essential for hemodialysis patients, optimal pharmaceutical treatment to maintain arteriovenous fistula (AVF) patency remains lacking. As cardiovascular diseases are highly prevalent in patients with end-stage
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ed3f8d05820e8257bdc68891600d6b7f
https://doi.org/10.1038/s41598-020-69019-6
https://doi.org/10.1038/s41598-020-69019-6
Autor:
Shing Jong Lin, Po Hsun Huang, Yuh Mou Sue, Chung-Te Liu, Chun Ming Shih, Chun You Chen, Shih Chang Hsu, Jaw Wen Chen, Hui Ling Hsieh, Feng Yen Lin, Wen Cheng Huang, Ho Shun Cheng
Publikováno v:
PLoS ONE, Vol 15, Iss 1, p e0228405 (2020)
PLoS ONE
PLoS ONE
Background Atrial fibrillation (AF) is highly prevalent, occurring in 1%–2% of the adult population, increasing the risk of stroke, and resulting in considerable healthcare costs. While stroke is a major complication of AF, end-stage renal disease
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7094a49382fe06ed8fb6284f2208474a
https://doi.org/10.1371/journal.pone.0228405
https://doi.org/10.1371/journal.pone.0228405
Autor:
Shing Jong Lin, Hui Ling Hsieh, Chun You Chen, Ho Shun Cheng, Cheng Hsien Chen, Yuh Mou Sue, Po Hsun Huang, Chung Te Liu, Te I. Chang, Chun Ming Shih, Shih Chang Hsu, Wen Cheng Huang, Jaw Wen Chen, Feng Yen Lin
Publikováno v:
Medicine
Introduction: Arteriovenous fistula (AVF) is the preferred vascular access for hemodialysis due to its higher patency and lower infection rate. However, its suboptimal maturation rate is a major weakness. Although substantial risk factors for AVF mat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2a9529023ee1b049597f141fecce5cec
https://doi.org/10.1097/md.0000000000017238
https://doi.org/10.1097/md.0000000000017238
Autor:
Ho-Shun Cheng, Te-I Chang, Cheng-Hsien Chen, Shih-Chang Hsu, Hui-Ling Hsieh, Chun-You Chen, Wen-Cheng Huang, Yuh-Mou Sue, Feng-Yen Lin, Chun-Ming Shih, Jaw-Wen Chen, Shing-Jong Lin, Po-Hsun Huang, Chung-Te Liu, Cheng, Ho-Shun, Chang, Te-I, Chen, Cheng-Hsien, Hsu, Shih-Chang, Hsieh, Hui-Ling, Chen, Chun-You
Publikováno v:
Medicine; Oct2019, Vol. 98 Issue 40, p1-5, 5p
Publikováno v:
Journal of Experimental & Clinical Medicine. 5:136-138
Background Generic-name drugs are chemically equivalent to their brand-name counterparts. However, the clinical efficacy and safety may not be equivalent between the brand-name (Lipanthyl) and generic-name (fenolip) fenofibrate in treating hypertrigl
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::17babb74d8c330435f99d47288e41117
https://doi.org/10.1016/j.jecm.2013.06.012
https://doi.org/10.1016/j.jecm.2013.06.012
Publikováno v:
Journal of Experimental & Clinical Medicine. 6:149-150
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::bd16a527f2ecc40e8c2b0ddb6a5c4bc8
https://doi.org/10.1016/j.jecm.2014.06.006
https://doi.org/10.1016/j.jecm.2014.06.006
Publikováno v:
Journal of Experimental & Clinical Medicine. 6:66-67
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::dfe4852424edb00fd77e5ff5d438f4e8
https://doi.org/10.1016/j.jecm.2014.02.003
https://doi.org/10.1016/j.jecm.2014.02.003
Publikováno v:
Journal of the Chinese Medical Association, Vol 77, Iss 2, Pp 108-111 (2014)
A female patient was admitted to our hospital for catheter ablation arising from paroxysmal supraventricular tachycardia (PSVT). In the laboratory, PSVT (the earliest retrograde atrial activation at the coronary sinus ostium) with intermittent atriov
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b8d7cbedf3235b1848812936e2764180